Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

E.; Ma

108 indexed publications match this author name.

ORCID
0000-0001-7909-5863
OpenAlex
https://openalex.org/A5140220796

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Dissociating the Hallucinogenic and Neuroplastic Effects of PsilocybinbioRxiv · 2026-07-08Psilocybin therapy for adult females with anorexia nervosa: pilot study.The British Journal of Psychiatry · 2026-07-07Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02Trials, trips, and tribulations: pathways for implementing psychedelic therapy in IrelandThe International Journal of Neuropsychopharmacology · 2026-05-08SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online surveyJournal of Psychedelic Studies · 2026-04-14Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis VolatilomeChemBioChem · 2026-03-31Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-30Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteersBMJ Open · 2026-02-28Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counselingTherapeutic Advances in Drug Safety · 2026-02-28Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intakeJournal of Analytical Toxicology · 2026-02-18Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compoundsJournal of Psychopharmacology · 2026-02-04Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay MenPalliative Medicine Reports · 2025-12-31Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2025-12-31COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISUnknown journal · 2025-12-10Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trialTranslational Psychiatry · 2025-11-12Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyBMJ Supportive & Palliative Care · 2025-11-02Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsNeuropharmacology · 2025-11-01Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trialsNeuropharmacology · 2025-10-16Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024Clinical Chemistry · 2025-09-30Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialPLoS Medicine · 2025-09-18Emerging mechanisms of psilocybin-induced neuroplasticity.Unknown journal · 2025-09-14Toward Standardized Products Containing Biomass of Psilocybe Cubensis FungiJournal of AOAC International · 2025-08-12Erin Mauney: Psychedelics as modulators of the gut-brain interactionPsychedelics. · 2025-06-02Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe MetabolomeChemBioChem · 2025-05-02FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A surveyJournal of Psychedelic Studies · 2025-04-21Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Unknown journal · 2025-04-21Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Unknown journal · 2025-04-14Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysisProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-03-31Psilocybin for disorders of consciousness: A case-report studyClinical Neurophysiology · 2025-03-07Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing MushroomsDrug Safety · 2025-03-03Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.Unknown journal · 2025-02-16Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive AgeDrug and Alcohol Dependence · 2025-01-31Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2024-12-31ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative studyPalliative & Supportive Care · 2024-09-30The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive EnhancementMiddle East Research Journal of Biological Sciences · 2024-09-27PTSD Treatment: An Inquiry into the Promising Potential of PsilocybinJournal of Advances in Medicine and Medical Research · 2024-07-23Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distressFrontiers in Psychiatry · 2024-04-17Mechanisms of therapeutic change after psychedelic treatment in OCDPsychiatry Research · 2024-04-06Psychedelic drugs and the law: What’s next?Knowable Magazine · 2024-03-13UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional studyBMJ Open · 2024-02-29Development of a digital intervention for psychedelic preparation (DIPP)Scientific Reports · 2024-02-18Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?Neuropsychopharmacology · 2024-01-10Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.Unknown journal · 2023-12-31Within-subject comparison of near-death and psychedelic experiences: acute and enduring effectsNeuroscience of Consciousness · 2023-12-31Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.Unknown journal · 2023-11-06Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesionsEuropean Archives of Psychiatry and Clinical Neuroscience · 2023-11-06The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studiesJournal of Psychopharmacology · 2023-10-30Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocolEuropean Journal of Trauma & Dissociation · 2023-10-24Expectancies for Subjective and Antidepressant Effects in Psilocybin UsersJournal of Humanistic Psychology · 2023-09-21Psilocybin history, action and reaction: A narrative clinical review.Unknown journal · 2023-08-30Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant DepressionUnknown journal · 2023-07-18Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and MeditationBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2023-07-16Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping reviewFrontiers in Psychiatry · 2023-06-25The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.Unknown journal · 2023-05-28Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autismmedRxiv · 2023-05-25Unblinding and demand characteristics in the treatment of depression.Journal of affective disorders · 2023-04-30In silico characterization of the psilocybin biosynthesis pathwayComputational Biology and Chemistry · 2023-03-22The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2022-12-31Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2022-12-31Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case reportHeliyon · 2022-11-30Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Kan psilocybin forbedre vores moral?Research at the University of Copenhagen (University of Copenhagen) · 2022-10-28Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Unknown journal · 2022-08-16The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The economics of psychedelic-assisted therapies: A research agenda.Frontiers in psychiatry · 2021-12-31Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of Psychopharmacology · 2021-12-16P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-11-30Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19Treatment-Resistant Depression: Approaches to Treatment.Unknown journal · 2021-08-31Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of Psychopharmacology · 2021-06-29Psilocybin: the magic medicine for depression?BJPsych Open · 2021-05-31Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2021-04-29Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsbioRxiv · 2021-01-28Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.Unknown journal · 2021-01-10Exploring moral bio-enhancement through psilocybin facilitated prosocial effectsResearch at the University of Copenhagen (University of Copenhagen) · 2020-12-31The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.Open Repository and Bibliography (University of Liège) · 2020-10-12Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyEClinicalMedicine · 2020-09-23Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancerJournal of Psychopharmacology · 2020-01-08P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personalityEuropean Neuropsychopharmacology · 2019-11-30The effects of psilocybin microdosing on perception: a double-blind controlled studyOSF Preprints (OSF Preprints) · 2019-01-30Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF).Neurocase · 2018-03-31The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers.Unknown journal · 2014-08-09Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.Molecular & Cellular Proteomics · 2014-03-16Altered states: psychedelics and anesthetics.Anesthesiology · 2013-11-30Magic truffles or Philosopher's stones: a legal way to sell psilocybin?Drug Testing and Analysis · 2012-08-08

Author directory

Carhart-Harris RL.59 publicationsRobin Carhart-Harris57 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ50 publicationsJohnson MW44 publicationsErritzoe D43 publicationsRoseman L41 publicationsBarrett FS.34 publicationsDavid Erritzøe34 publicationsDavid Nutt34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsRoland R. Griffiths28 publicationsHendricks PS27 publicationsFranz X. Vollenweider24 publicationsGitte M. Knudsen24 publicationsRosenblat JD24 publicationsGarcia-Romeu A23 publicationsKatrin H. Preller23 publicationsAlbert Garcia-Romeu22 publicationsPatrick M. Fisher22 publicationsPáleníček T.22 publicationsSandeep M. Nayak22 publicationsTomáš Páleníček22 publicationsDea Siggaard Stenbæk21 publicationsFisher PM21 publicationsMatthew W. Johnson21 publicationsDavis AK20 publicationsFrederick S. Barrett20 publicationsMcIntyre RS20 publicationsJames Rucker19 publicationsKargbo RB.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDirk Hoffmeister18 publicationsDos Santos RG18 publicationsHusain MI18 publicationsLiechti ME18 publicationsM. Madsen18 publicationsNathan D. Sepeda18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsGuy M. Goodwin17 publicationsKuypers KPC.17 publicationsSimonsson O17 publicationsBrice Ozenne16 publicationsHannes Kettner16 publicationsKringelbach ML.16 publicationsKwan AC.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsYale University16 publicationsFischer R.15 publicationsGonzález-Maeso J15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsMadsen MK15 publicationsMason NL.15 publicationsMatthias E. Liechti15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsAlan K. Davis14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKim P. C. Kuypers14 publicationsKometer M14 publicationsManish Agrawal14 publicationsMuhammad Ishrat Husain14 publicationsNayak SM14 publicationsBasel13 publicationsDavid J. Hellerstein13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsNatasha L. Mason13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsDavid B. Yaden12 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJoshua Woolley12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMartin Kuchař12 publicationsMcCulloch DE12 publicationsPeter S. Hendricks12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsStephen Ross12 publicationsWang X12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsAlexander M. Sherwood11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsFriederike Holze11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsKaelen M11 publicationsLeor Roseman11 publicationsMichael P. Bogenschutz11 publicationsNichols CD.11 publicationsOsika W11 publicationsRoger S. McIntyre11 publicationsScott T. Aaronson11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsCharles D. Nichols10 publicationsChristopher Timmermann10 publicationsDavoudian PA10 publicationsDrummond E-Wen McCulloch10 publications